MJ Holdings, Inc., through its subsidiaries, operates in the medical marijuana business in Nevada. More Details
Mediocre balance sheet and overvalued.
Share Price & News
How has MJ Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MJNE's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: MJNE underperformed the US Pharmaceuticals industry which returned 1.5% over the past year.
Return vs Market: MJNE underperformed the US Market which returned 12% over the past year.
Price Volatility Vs. Market
How volatile is MJ Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is MJ Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate MJNE's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate MJNE's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: MJNE is unprofitable, so we can't compare its PE Ratio to the US Pharmaceuticals industry average.
PE vs Market: MJNE is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MJNE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MJNE is good value based on its PB Ratio (1.7x) compared to the US Pharmaceuticals industry average (2.9x).
How is MJ Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MJ Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of MJNE’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access MJ Holdings's filings and announcementshere.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has MJ Holdings performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: MJNE is currently unprofitable.
Growing Profit Margin: MJNE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MJNE's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MJNE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MJNE is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (18.7%).
Return on Equity
High ROE: MJNE has a negative Return on Equity (-124.73%), as it is currently unprofitable.
How is MJ Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: MJNE's short term assets ($3.5M) exceed its short term liabilities ($1.6M).
Long Term Liabilities: MJNE's short term assets ($3.5M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: MJNE's debt to equity ratio (36.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if MJNE's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if MJNE has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MJNE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is MJ Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MJNE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MJNE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MJNE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MJNE's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MJNE's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Roger Bloss (63 yo)
Mr. Roger J. Bloss is the Director at MJ Holdings, Inc. since April 1, 2019 and also serves as its Interim Chief Executive Officer since September 2020. He serves as Board Adviser at InsuraGuest Technologi ...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
MJ Holdings, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: MJ Holdings, Inc.
- Ticker: MJNE
- Exchange: OTCPK
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$10.455m
- Shares outstanding: 65.76m
- Website: https://www.mjholdingsinc.com
Number of Employees
- MJ Holdings, Inc.
- 3275 South Jones Boulevard
- Las Vegas
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MJNE||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Dec 2017|
MJ Holdings, Inc., through its subsidiaries, operates in the medical marijuana business in Nevada. It offers cultivation management, licensing support, production management, and asset and infrastructure d ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/30 03:50|
|End of Day Share Price||2020/10/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.